公开(公告)号：US20230322900A1

公开(公告)日：2023-10-12

申请号：US18064571

申请日：2022-12-12

Applicant: BIOVERATIV THERAPEUTICS INC.

Inventor： Volker Schellenberger ,  Pei-Yun Chang ,  Fatbardha Varfaj ,  Sheng Ding ,  Joshua Silverman ,  Chia-wei Wang ,  Benjamin Spink ,  Willem P. Stemmer ,  Nathan Geething ,  John Kulman ,  Tongyao Liu ,  Garabet G. Toby ,  Haiyan Jiang ,  Robert Peters ,  Deping Wang ,  Baisong Mei

IPC: C07K14/755

CPC classification number: C07K14/755 ,  A61K38/00

Abstract: The present invention relates to compositions comprising factor VIII coagulation factors linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of factor VIII-related diseases, disorders, and conditions.

公开(公告)号：US20200087379A1

公开(公告)日：2020-03-19

申请号：US16521789

申请日：2019-07-25

Applicant: BIOVERATIV THERAPEUTICS INC.

Inventor： Volker Schellenberger ,  Pei-Yun Chang ,  Fatbardha Varfaj ,  Sheng Ding ,  Joshua Silverman ,  Chia-wei Wang ,  Benjamin Spink ,  Willem P. Stemmer ,  Nathan Geething ,  John Kulman ,  Tongyao Liu ,  Garabet G. Toby ,  Haiyan Jiang ,  Robert Peters ,  Deping Wang ,  Baisong Mei

IPC: C07K14/755

Abstract: The present invention relates to compositions comprising factor VIII coagulation factors linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of factor VIII-related diseases, disorders, and conditions.